[Suppression of chloroquine resistance in Plasmodium berghei by using a microsomal monooxygenase inhibitor].
D000818:Animals; D002738:Chloroquine / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D003300:Copper / Q000627:therapeutic use*; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D008239:Lysine / Q000627:therapeutic use*; D008288:Malaria / Q000188:drug therapy / Q000469:parasitology; D051379:Mice; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology*; D010105:Oxygenases / Q000037:antagonists & inhibitors*; D010962:Plasmodium berghei / Q000187:drug effects* / Q000201:enzymology
D004338:Drug Combinations; D003300:Copper; D002738:Chloroquine; D010105:Oxygenases; D008239:Lysine
Podavlenie ustoĭchivosti k khlorokhinu u Plasmodium berghei s pomoshch'iu ingibitora mikrosomal'nykh monooksigenaz.